And to be clear, Im a fan of all three of the above products
If a clinician is trying to upsell you on a higher dose, its a major red flagmicrodosing programs shouldnt be pushing escalation unless its clinically necessary
In other countries, Moderna is making a JN.1 version of the vaccine, the company said in a statement
Medicine and lifestyle must work together, not replace each other GLP1 agonists are currently used more in the treatment of obesity than diabetes...they have created a good market in the obesity sector
(Second E.) 277307, (Elsevier, 2010)
These complexes work sequentially to transfer electrons, establish a proton gradient, and drive ATP synthesis